Family Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Buy
3,794
+2,859
+306% +$2.19M 0.35% 72
2025
Q4
$722K Sell
935
-52
-5% -$35.3K 0.09% 117
2025
Q3
$555K Sell
987
-3,079
-76% -$1.74M 0.08% 121
2025
Q2
$2.13M Sell
4,066
-138
-3% -$77K 0.32% 73
2025
Q1
$2.67M Buy
4,204
+80
+2% +$55K 0.44% 60
2024
Q4
$2.94M Buy
4,124
+124
+3% +$104K 0.48% 51
2024
Q3
$4.2M Sell
4,000
-2,650
-40% -$2.95M 0.7% 37
2024
Q2
$6.99M Buy
6,650
+374
+6% +$363K 1.24% 19
2024
Q1
$6.04M Buy
6,276
+577
+10% +$549K 1.12% 22
2023
Q4
$5.01M Sell
5,699
-443
-7% -$365K 1.04% 25
2023
Q3
$5.05M Sell
6,142
-63
-1% -$49.5K 1.16% 23
2023
Q2
$4.46M Sell
6,205
-86
-1% -$66.3K 0.98% 26
2023
Q1
$5.17M Buy
6,291
+320
+5% +$241K 1.19% 25
2022
Q4
$4.31M Sell
5,971
-65
-1% -$48K 1.05% 28
2022
Q3
$4.16M Sell
6,036
-66
-1% -$41.5K 1.12% 25
2022
Q2
$3.61M Sell
6,102
-269
-4% -$175K 1.03% 30
2022
Q1
$4.45M Sell
6,371
-13
-0.2% -$8.22K 1.23% 23
2021
Q4
$4.03M Buy
6,384
+119
+2% +$73.2K 1.05% 31
2021
Q3
$3.79M Buy
6,265
+61
+1% +$37.9K 1.05% 31
2021
Q2
$3.46M Sell
6,204
-882
-12% -$447K 0.92% 34
2021
Q1
$3.35M Buy
7,086
+63
+0.9% +$30.7K 1.05% 31
2020
Q4
$3.39M Buy
7,023
+1,796
+34% +$969K 1.17% 31
2020
Q3
$2.93M Sell
5,227
-1,457
-22% -$883K 1.28% 26
2020
Q2
$4.17M Sell
6,684
-1,920
-22% -$1.09M 1.7% 15
2020
Q1
$4.2M Sell
8,604
-112
-1% -$46.2K 2.1% 10
2019
Q4
$3.27M Sell
8,716
-14
-0.2% -$4.71K 1.13% 29
2019
Q3
$2.42M Sell
8,730
-7
-0.1% -$2.07K 0.9% 35
2019
Q2
$2.73M Buy
8,737
+134
+2% +$44.6K 1.08% 31
2019
Q1
$3.53M Buy
8,603
+4,087
+91% +$1.68M 1.53% 15
2018
Q4
$1.69M Buy
+4,516
New +$1.65M 0.71% 42

Other funds holding REGN